Results 151 to 160 of about 1,809 (187)

Trend towards reduction of transfusion reactions using prestorage leukocyte-reduced and pooled whole blood-derived platelets and cost savings compared with poststorage whole blood-derived random platelets as evidenced by real-time hemovigilance.

Laboratoriums Medizin
BACKGROUND Due to chemotherapy-induced neutropenia or hematologic malignancies, immunocompromised cancer patients may have higher incidence of febrile nonhemolytic transfusion reactions compared with the general population and frequently require platelet
Nick Park, Mayrin Correa Medina, Fernando Martinez, Marla Throssel, A. DasGupta, A. Knopfelmacher, Colleen Villamin, Sandra Rivas, Nancy Tomczak, Saahith Garg, Lorraine Layton, Kimberly Klein   +11 more
semanticscholar   +1 more source

Keeping The Stock Alive, A Dilemma of Hemovigilance

American Journal of Clinical Pathology
Being well-prepared for emergent blood transfusions is crucial in level 1 trauma centers. As advocates of hemovigilance, we follow protocols that encourage the appropriate use of group O, D- (O-) pRBCs.
A. Haque, M. Agaronov, D. Talabong, J. Ngichabe, E. Yakut, T. Rana-Gupta, E. Gabutan, S. Kang   +7 more
semanticscholar   +1 more source

Hemovigilance in the United States of America

Vox Sanguinis, 1998
AbstractAlthough hemovigilance is not a word used commonly in the United States, the concept of monitoring morbidity associated with blood transfusion is accepted widely. Currently, quality management focuses on error avoidance rather than error detection in both the “manufacturing” and “clinical” aspects of blood banking.
openaire   +2 more sources

Transfusion reactions: a challenge in hemovigilance

II SEVEN INTERNATIONAL CONGRESS OF HEALTH, 2023
Hemovigilance is the set of surveillance procedures that covers the entire blood cycle, in order to obtain and make available information on adverse events occurring at different stages to prevent their occurrence or recurrence, improve the quality of processes and products and increase the safety of the donor and recipient. Objetivo: conhecer o perfil
openaire   +1 more source

Incorporating the concept of overtransfusion into hemovigilance monitoring: An expert‐based definition and criteria from the International HIT‐OVER Forum

Transfusion
Liberal or overtransfusion (OT) may be regarded as “inappropriate,” but it is not reported as a transfusion‐related adverse event. A definition of OT is lacking.
D. Fischer, M. A. Weigand, R. Moss, S. Veiras, B. Kübel, J. A. García-Erce, K. Zacharowski, P. Meybohm, J. Waters, S. J. Raasveld, A. Vlaar, T. Richards, J. Meier, S. Lasocki, A. Hofmann, A. Shander, C. Heymann, G. Dietrich, D. Fries, A. Steinbicker, M. B. Rondinelli, J. Levy, G. Beck, T. Frietsch   +23 more
semanticscholar   +1 more source

Identification of operational errors in the stages of the hemovigilance program with the guidance of the Global Trigger Tool and comparing it with the reported errors

The Scientific Journal of Iranian Blood Transfusion Organization
.
M. Mojahed, S. Besharati, B. Farzanegan, ُS Mahmoudian, M. Hosseini, M. Yarinejad, S.K Mousavi, A. Rahimzadeh Kalaleh   +7 more
semanticscholar   +1 more source

Delayed hemolytic transfusion reaction in the French hemovigilance system

Transfusion Clinique et Biologique, 2019
In France, reporting of adverse events related, or likely to be related, to transfusion is mandatory. Since its creation in 1993, the French hemovigilance system has contributed to a better recognition of unappreciated risks like delayed hemolytic transfusion reactions (DHTR) in sickle-cell disease (SCD) patients.
C, Rieux, G, Brittenham, D, Bachir, E, De Meyer, K, Boudjedir   +4 more
openaire   +2 more sources

Impact of the platelet storage time on transfusion-related adverse reactions: A French hemovigilance study.

Transfusion Clinique et Biologique
BACKGROUND The legal shelf life of platelet concentrates (PCs) has been extended from 5 to 7 days in France since 2018. Our study aimed to determine whether this increase in PC storage time has produced a significant impact on transfusion-related adverse
Juliana Pires Marafon, Sophie Reuter, H. Isola, Sophie Somme, Blandine Maître   +4 more
semanticscholar   +1 more source

[Hemovigilance: State 2007-2013 Tunis].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 2018
Despite its lifesaving role, blood transfusion still has risks associated with it. Hemovigilance is a set of surveillance procedures of the transfusion chain intended to promote safe and effective use of blood components. This work aims to present a descriptive analysis of adverse reactions, which were notified over a period of 5 years (incidence and ...
S, Mahjoub, H, Baccouche, A, Raissi, L, Ben Hamed, N, Ben Romdhane   +4 more
openaire   +1 more source

[What is the use of hemovigilance?].

Transfusion clinique et biologique : journal de la Societe francaise de transfusion sanguine, 1999
The French Blood Agency has developed a national system of surveillance and alert, from blood collection to the follow-up of the recipients, called haemovigilance. The French haemovigilance network is now operational, and aims at detecting, gathering and analysing unexpected or undesirable effects associated with transfusion in order to remedy their ...
J F, Quaranta, N, Canivet
openaire   +1 more source